Test your knowledge on cytopenias after CAR T-cell therapy

Reported rates of prolonged or recurrent cytopenias (grade 3 or higher lasting more than 30 days) can be found in what percentage range of CAR T-cell therapy recipients:
1% to 5%
5% to 15%
20% to 40%
60% to 90%
The only cause of prolonged cytopenias after CAR-T cell therapy is cytokine release syndrome (CRS).
True
False
Management of prolonged cytopenias includes, but is not limited to, which of the following?
Packed red blood cell transfusions
Granulocyte-colony stimulating factor (G-CSF)
Bacterial and fungal infection prophylactic agents
All of the abov
It can be definitively stated that CAR T-cell therapy constructs themselves have no role in the development of prolonged cytopenias.
True
False
0
{"name":"Test your knowledge on cytopenias after CAR T-cell therapy", "url":"https://www.poll-maker.com/QLQHLN5K7","txt":"Reported rates of prolonged or recurrent cytopenias (grade 3 or higher lasting more than 30 days) can be found in what percentage range of CAR T-cell therapy recipients:, The only cause of prolonged cytopenias after CAR-T cell therapy is cytokine release syndrome (CRS)., Management of prolonged cytopenias includes, but is not limited to, which of the following?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}